Garenne M, Candau D, Guimier J-M, Badiane M, Diop A C, Teulières L C
IRD, Paris, France.
Trop Doct. 2006 Jan;36(1):5-8. doi: 10.1258/004947506775598851.
The survey was conducted in Senegal in April 2001 on a representative sample of providers and clients. Results show that access to medicines in Senegal was limited for three main reasons: (1) the supply of drugs was inadequate, and even critical drugs were often missing in health centres, and were somewhat less in pharmacies; (2) the health infrastructures appeared insufficient to cover the needs of the whole population, creating high opportunity costs; (3) the cost of the drugs prescribed was higher than the minimum price, sometimes exceeding the capacity of poorer people, although high cost was seldom reported as the main reason for not acquiring prescribed drugs. Improving access to medicine is a priority to help reduce health inequalities in developing countries.
2001年4月在塞内加尔对供应商和客户的代表性样本进行了调查。结果表明,塞内加尔的药品获取受限主要有三个原因:(1) 药品供应不足,甚至保健中心经常缺少关键药品,药店的此类药品也有所减少;(2) 卫生基础设施似乎不足以满足全体人口的需求,造成了高昂的机会成本;(3) 所开药品的费用高于最低价格,有时超出了穷人的承受能力,不过很少有人将高费用报告为未购买所开药品的主要原因。改善药品获取是帮助减少发展中国家健康不平等现象的一项优先任务。